HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Future DSHEA Challengers Will Learn From McCain Bill Failure - NPA

This article was originally published in The Tan Sheet

Executive Summary

Sponsors of future challenges to DSHEA likely will learn from the missteps in legislation Sen. John McCain introduced in February, according to Natural Products Association Executive Director John Gay

You may also be interested in...

FDA Oversight Among Hot Button Issues In 112th Congress

Health care reform and oversight of FDA remain hot button issues in the 112th Congress, industry advocates say.

FDA Tainted Supplement Alert Could Set Stage For Rapid Enforcement

A week after FDA warned manufacturers about tighter enforcement against tainted dietary supplements, a MedWatch notice identifies an adulterated weight-loss product that appears to fit the agency's criteria for warranting regulatory action.

FDA Drives Parallel Food Safety Reform Agenda As Legislation Chances Fade

FDA is wielding additional food safety enforcement tools regardless of whether Congress passes reform legislation before the current session ends.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts